Mar 02, 2023 / 07:00PM GMT
Daniel R. Grosslight - Citigroup Inc., Research Division - Research Analyst
All right. Good afternoon, everyone, and thanks for joining us for the MultiPlan fireside chat here at the Citi Healthcare Conference. My name is Daniel Grosslight. I'm the healthcare technology analyst here at Citi, and I'm pleased to welcome Dale White, the CEO of MultiPlan and Jim Head, the CFO of MultiPlan. Thanks both for joining us here.
James M. Head - MultiPlan Corporation - CFO & Executive VP
Thank you.
Daniel R. Grosslight - Citigroup Inc., Research Division - Research Analyst
I'm sure I don't have to tell you this or anyone in the room that it's been a little bit of a wild ride for MultiPlan since you guys went public via AD stacking. So I'd like to focus maybe our conversation, at least upfront on a few of the big controversies that I've talked to investors about quite frequently. The first one would be on just revenue visibility, particularly given some utilization challenges more recently. The second one would be competition
Multiplan Corp at Citi Healthcare & Medtech Conference Transcript
Mar 03, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers